Sign in

CIK 0001600620

  • Large accelerated filer

Aurinia Pharmaceuticals Inc.

Sign in to watch
Ticker
AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981231763
Phone
+1 250-744-2487
Business address
#140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
  1. 4 Open-market sale Chief Executive Officer sold 360,540 shares at an average $7.96 ($2,871,124)
  2. 4 Open-market sale Chief Medical Officer sold 12,239 shares at $8.00 ($97,912)
  3. 4 Open-market sale Chief Financial Officer sold 118,013 shares at an average $7.96 ($939,612)
  4. 4 Open-market sale EVP, General Counsel sold 122,479 shares at an average $7.96 ($975,223)
  5. 4 Open-market sale Chief Operating Officer sold 124,893 shares at an average $7.96 ($994,425)
  6. 4 Open-market buy Director bought 1,600,000 shares at an average $7.95 ($12,713,126)
  7. 4 Open-market buy Director bought 1,200,000 shares at an average $9.02 ($10,822,000)
  8. 4 Grant or award Director acquired 12,135 shares (grant or award)
  9. 4 Grant or award Director acquired 12,135 shares (grant or award)
  10. 4 Grant or award Director acquired 20,631 shares (grant or award)
  11. 4 Grant or award Director acquired 12,135 shares (grant or award)
  12. 4 Grant or award Director acquired 12,135 shares (grant or award)
  13. 4 Open-market sale Director sold 4,557 shares at $8.43 ($38,416)
  14. 4 Open-market sale Director sold 5,241 shares at $8.43 ($44,182)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Open-market sale Chief Commercial Officer sold 18,249 shares at $5.31 ($96,902)
  20. 4 Open-market sale Director sold 520 shares at $5.74 ($2,985)

Page 3 of 10 · 184 filings